CS
VCYT icon

Credit Suisse’s Veracyte VCYT Stock Holding History

Credit Suisse’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.12M Buy
95,773
+6
+0% +$146 ﹤0.01% 1816
2023
Q4 		$2.63M Buy
95,767
+4,319
+5% +$104K ﹤0.01% 1724
2023
Q3 		$2.04M Sell
91,448
-10,628
-10% -$273K ﹤0.01% 1826
2023
Q2 		$2.6M Buy
102,076
+21,923
+27% +$531K ﹤0.01% 1748
2023
Q1 		$1.79M Buy
80,153
+2,297
+3% +$55.5K ﹤0.01% 1949
2022
Q4 		$1.85M Buy
77,856
+3,840
+5% +$89.2K ﹤0.01% 1929
2022
Q3 		$1.23M Buy
74,016
+454
+0.6% +$10.2K ﹤0.01% 2181
2022
Q2 		$1.46M Sell
73,562
-5,067
-6% -$102K ﹤0.01% 2121
2022
Q1 		$2.17M Buy
78,629
+4,769
+6% +$136K ﹤0.01% 2025
2021
Q4 		$3.04M Buy
73,860
+4,885
+7% +$216K ﹤0.01% 2431
2021
Q3 		$3.2M Buy
68,975
+5,072
+8% +$221K ﹤0.01% 2425
2021
Q2 		$2.56M Buy
63,903
+5,296
+9% +$226K ﹤0.01% 2661
2021
Q1 		$3.15M Sell
58,607
-38,387
-40% -$2.21M ﹤0.01% 2481
2020
Q4 		$4.75M Buy
96,994
+17,501
+22% +$811K ﹤0.01% 2130
2020
Q3 		$2.58M Sell
79,493
-52,420
-40% -$1.67M ﹤0.01% 2234
2020
Q2 		$3.42M Buy
131,913
+34,438
+35% +$858K ﹤0.01% 1965
2020
Q1 		$2.37M Sell
97,475
-27,494
-22% -$692K ﹤0.01% 2019
2019
Q4 		$3.49M Buy
124,969
+15,533
+14% +$402K ﹤0.01% 2156
2019
Q3 		$2.63M Sell
109,436
-26,591
-20% -$707K ﹤0.01% 2276
2019
Q2 		$3.88M Buy
+136,027
New +$3.4M ﹤0.01% 1949
2018
Q2 		– Sell
-10,860
Closed -$60K – 4154
2018
Q1 		$60K Buy
+10,860
New +$67.2K ﹤0.01% 3865
2017
Q4 		– Sell
-16,015
Closed -$141K – 4205
2017
Q3 		$141K Buy
+16,015
New +$130K ﹤0.01% 4019
2015
Q3 		– Sell
-10,359
Closed -$115K – 4485
2015
Q2 		$115K Buy
+10,359
New +$102K ﹤0.01% 4361
2014
Q4 		– Sell
-31,720
Closed -$309K – 4736
2014
Q3 		$309K Buy
+31,720
New +$416K ﹤0.01% 3923

Other funds holding VCYT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse's VCYT Position: Q1 2024 in Review

Credit Suisse increased its Veracyte (VCYT) stake by 0.01% in Q1 2024, buying an estimated $146 and bringing the position to 95,773 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Credit Suisse first reported a position in VCYT in Q3 2014 and has held it in 24 quarters since. The position peaked at $4.75M in Q4 2020. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.

  • Credit Suisse held 95,773 shares of Veracyte worth $2.12M as of Q1 2024.
  • Credit Suisse bought 6 Veracyte shares in Q1 2024, an estimated $146.
  • Veracyte made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1816 holding.
  • Credit Suisse first reported a position in Veracyte in Q3 2014 and has held it in 24 quarters since.
  • Credit Suisse's Veracyte position peaked at $4.75M in Q4 2020.
  • 246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.